The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease.

Wang Y, Li H, Zhou J, Zhao S, Yang A, Li Z

DOI: 10.3389/fneur.2026.1761380
Published: 2026
Container: Frontiers in neurology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fneur.2026.1761380,
  title = {The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease.},
  author = {Wang Y and Li H and Zhou J and Zhao S and Yang A and Li Z},
  year = {2026},
  journal = {Frontiers in neurology},
  doi = {10.3389/fneur.2026.1761380},
  url = {https://doi.org/10.3389/fneur.2026.1761380}
}

RIS

TY  - JOUR
TI  - The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease.
AU  - Wang Y
AU  - Li H
AU  - Zhou J
AU  - Zhao S
AU  - Yang A
AU  - Li Z
PY  - 2026
JO  - Frontiers in neurology
DO  - 10.3389/fneur.2026.1761380
UR  - https://doi.org/10.3389/fneur.2026.1761380
ER  -

APA

Y, W., H, L., J, Z., S, Z., A, Y., & Z, L. (2026). The clinical value of multimodal neuroimaging in monoclonal antibody therapy for Alzheimer's disease.. Frontiers in neurology. https://doi.org/10.3389/fneur.2026.1761380

Source records

pubmed · retrieved 2026-09-26T04:21:45.889Z